Treating cystic fibrosis infection, inflammation and ion channels
Achieving optimal bone health in cystic fibrosis: ready for prime time?
Heteroresistance of opportunistic bacteria to antimicrobial peptides: a new challenge to antimicrobial therapy of cystic fibrosis infections
Unconventional trafficking pathway may lead to cystic fibrosis therapeutics
Women and the poor with cystic fibrosis still have worse prognosis, according to recent report
Cystic fibrosis treatment under threat from £6 million cash deficit
Deletion of the ubiquitin ligase Nedd4L in lung epithelia causes cystic fibrosis-like disease
Standardized scoring of chest CT scans can predict future lung function in cystic fibrosis
Lung clearance index and standardized scoring of chest CT scans measure different aspects of lung function in cystic fibrosis
No advantage to bronchoalveolar lavage cultures over oropharyngeal cultures in cystic fibrosis early stage lung infections
Clinical trial of inhaled levofloxacin in cystic fibrosis demonstrates a reduction in concentration of Pseudomonas aeruginosa in the airways of cystic fibrosis subjects
Lack of common proteostatic patterns of gene expression between correctors of F508del-CFTR trafficking suggests multiple therapeutic targets may be required for effective restoration of CFTR
Interview: Gene therapy for cystic fibrosis: future hopes and milestones
Treatment of cystic fibrosis following infant screening
Treatment of pulmonary exacerbations in cystic fibrosis
The airway microbiome in cystic fibrosis: challenges for therapy
Ion channel regulators for the treatment of cystic fibrosis
Into the age of reanimation: promise and challenge in cardiac arrest care
Novel animal study suggests potential treatment for tumor-associated epilepsy
Pivotal Phase III study demonstrates substantial symptom relief in patients with systemic juvenile idiopathic arthritis treated with canakinumab
Glucagon-like peptide-1-based therapy for diabetes may be linked to an increased risk of pancreatic cancer
Study demonstrates upfront combination chemotherapy is not more effective than sequential use of chemotherapy in patients with advanced, nonresectable colorectal cancer
Dronedarone (Multaq®) for the treatment of atrial fibrillation
Solifenacin for the treatment of overactive bladder
Vildagliptin for the treatment of diabetes
Improving cardiac arrest survival by providing high quality, co-ordinated care: 2010 International Liaison Committee on Resuscitation guidelines
Cardiovascular disease and venous thromboembolism in inflammatory bowel disease
Targeting epithelial–mesenchymal transition: therapeutic reversal of the cancer stem cell phenotype
The antiviral resistance of influenza virus
Axial neck pain: a surgeon’s perspective
Acknowledgements